Your browser doesn't support javascript.
loading
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.
Davis, Elizabeth J; Martin-Liberal, Juan; Kristeleit, Rebecca; Cho, Daniel C; Blagden, Sarah P; Berthold, Dominik; Cardin, Dana B; Vieito, Maria; Miller, Rowan E; Hari Dass, Prashanth; Orcurto, Angela; Spencer, Kristen; Janik, John E; Clark, Jason; Condamine, Thomas; Pulini, Jennifer; Chen, Xuejun; Mehnert, Janice M.
Afiliação
  • Davis EJ; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Martin-Liberal J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Kristeleit R; Research Department of Oncology, University College London, London, UK.
  • Cho DC; Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, USA.
  • Blagden SP; Department of Oncology, University of Oxford, Oxford, UK.
  • Berthold D; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Cardin DB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vieito M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Miller RE; University College London Hospital, London, UK.
  • Hari Dass P; Early Phase Clinical Trials Unit, Churchill Hospital, University of Oxford, Oxford, UK.
  • Orcurto A; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Spencer K; Rutgers University, New Brunswick, New Jersey, USA.
  • Janik JE; Incyte Corporation, Wilmington, Delaware, USA.
  • Clark J; Incyte Corporation, Wilmington, Delaware, USA.
  • Condamine T; Incyte Corporation, Wilmington, Delaware, USA.
  • Pulini J; Incyte Corporation, Wilmington, Delaware, USA.
  • Chen X; Incyte Corporation, Wilmington, Delaware, USA.
  • Mehnert JM; Rutgers University, New Brunswick, New Jersey, USA janice.mehnert@nyulangone.org.
J Immunother Cancer ; 10(10)2022 10.
Article em En | MEDLINE | ID: mdl-36316061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos